Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514215, 514237, 514318, 514332, 514335, 514340, 514343, 514351, 514357, 546194, 546256, 546261, 546264, 546296, 546300, 546281, 546272, 546275, 546334, 544 60, 544124, C07D21363, C07D21350, C07D40106, A61K 3144

Patent

active

045393168

ABSTRACT:
Compounds of the formula ##STR1## wherein R.sup.12 is a leaving group, Z is S, O or CH.sub.2 and A is a phenyl, furyl, thienyl or pyridyl ring substituted by a ##STR2## moiety, in which R.sup.8 and R.sup.9 are various substituents or, when taken together with the nitrogen, may be a specified heterocyclic ring, are intermediates in the preparation of histamine H.sub.2 -antagonist anti-ulcer agents of the formula ##STR3## in which R.sup.1 and R.sup.2 are any of several specified substituents.

REFERENCES:
patent: 4062863 (1977-12-01), Ganellin et al.
patent: 4233302 (1980-11-01), Martin-Smith et al.
patent: 4242350 (1980-12-01), Yellin et al.
patent: 4242351 (1980-12-01), Yellin et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-613861

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.